Euromonitor International's Shane MacGuill, Head of Nicotine and Cannabis research, spoke recently to leading independent podcast The Cannabis Review about how we developed our research and analysis on the emerging legal cannabinoid space, how it interacts with other CPG industries and the future evolution of the European market.
The global market for legalised cannabis was worth USD41 billion in 2022 and is projected to generate USD100 billion by 2027, according to Euromonitor International. Due to its small customer base, the Czech Republic accounts for just 0.1% of the total worth of European value.
Euromonitor's Head of Tobacco Research, Shane MacGuill, reflects on the 2023 International Cannabis Business Conference in Barcelona, at which he hosted a panel discussion with industry veterans.
After a booming summer for socialising, things are starting to cool off. Inflation and the cost of living crisis are catching up with consumers who might still have some pent-up desire to go out. These conflicting desires leave consumers dangling between spend and save, while still looking for ways to continue their social lives.
As cannabis starts to appear in the headlines around the world, both consumers and companies have started to show interest in experimenting with cannabis products.
The tobacco and nicotine market is changing rapidly and the environment in which it operates is more turbulent than ever. Euromonitor is delighted to introduce a new tool, the Tobacco Forecast Model, that can assist in plotting a course through this disruption and navigate future market evolution.
In 2022, Euromonitor researched the Japanese cannabis market for the first time. While only in its initial stages, there are high growth opportunities, particularly among health-conscious Japanese consumers, given inherent demand for better sleep and pain relief.
The US dominates the global cannabis market, generating 81% total value share in 2021. At the same time, European countries account for 8% share of worldwide value following Canada with 9%. Poland is responsible for an 8% value share of European countries; adult-use is prohibited by law, medical cannabis is only legal with a prescription, while CBD is freely available.